RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Michael J Gonzalez to Cell Line, Tumor

This is a "connection" page, showing publications Michael J Gonzalez has written about Cell Line, Tumor.
Connection Strength

0.258
  1. Casciari JJ, Riordan HD, Miranda-Massari JR, Gonzalez MJ. Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs. P R Health Sci J. 2005 Jun; 24(2):145-50.
    View in: PubMed
    Score: 0.161
  2. Gonzalez MA, Tachibana KE, Chin SF, Callagy G, Madine MA, Vowler SL, Pinder SE, Laskey RA, Coleman N. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol. 2004 Oct; 204(2):121-30.
    View in: PubMed
    Score: 0.038
  3. Meng X, Riordan NH, Riordan HD, Mikirova N, Jackson J, Gonz?lez MJ, Miranda-Massari JR, Mora E, Trinidad Castillo W. Cell membrane fatty acid composition differs between normal and malignant cell lines. P R Health Sci J. 2004 Jun; 23(2):103-6.
    View in: PubMed
    Score: 0.037
  4. Vaddula BR, Tantak MP, Sadana R, Gonzalez MA, Kumar D. One-pot synthesis and in-vitro anticancer evaluation of 5-(2'-indolyl)thiazoles. Sci Rep. 2016 Mar 29; 6:23401.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support